Senator Peter Welch @PeterWelch
Today, I sent a letter to the CEO of @biogen demanding to know how the company justified pricing their new Alzheimer’s drug at $56k/year. This blatant abuse of pricing power makes the promise of this drug unreachable for many of the 6M Americans living with Alzheimer’s. Read ⬇️: https://t.co/RVUVAztDZi — PolitiTweet.org